| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/06/2009 | US20090197287 Systems and methods for characterizing kidney disease |
| 08/06/2009 | US20090197279 Microtubule synthesis as a biomarker |
| 08/06/2009 | US20090197277 High Density Plate Filler |
| 08/06/2009 | US20090197276 Methods and compositions for predicting compliance with an antidepressant treatment regimen |
| 08/06/2009 | US20090197275 Controls For Detecting Methicillin Resistant Staphylococcus Aureus (MRSA) |
| 08/06/2009 | US20090197274 Biological sample reaction chip and biological sample reaction method |
| 08/06/2009 | US20090197273 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 08/06/2009 | US20090197272 Vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry |
| 08/06/2009 | US20090197271 Functional nucleic acid ligands to fluorescent proteins |
| 08/06/2009 | US20090197270 Diagnostic assay for spongiform encephalopathies |
| 08/06/2009 | US20090197269 Translocation and mutant CSF1R Kinase in human leukemia |
| 08/06/2009 | US20090197268 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 08/06/2009 | US20090197267 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 08/06/2009 | US20090197266 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 08/06/2009 | US20090197265 Epigenetic analyses |
| 08/06/2009 | US20090197264 Method for prediction of sensitivity to 5-fluorouracil-type anticancer agent |
| 08/06/2009 | US20090197263 Compare-MS: Method Rapid, Sensitive and Accurate Detection of DNA Methylation |
| 08/06/2009 | US20090197262 Bordetella detection assay |
| 08/06/2009 | US20090197261 Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes |
| 08/06/2009 | US20090197260 Method for predicting the viability and vitality of bacteria usable in stressing environment |
| 08/06/2009 | US20090197259 Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer |
| 08/06/2009 | US20090197258 Primary rat hepatocyte toxicity modeling |
| 08/06/2009 | US20090197257 Paired-end reads in sequencing by synthesis |
| 08/06/2009 | US20090197256 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 08/06/2009 | US20090197255 Determining a predisposition to cancer |
| 08/06/2009 | US20090197254 Variant scorpion primers for nucleic acid amplification and detection |
| 08/06/2009 | US20090197253 High frequency of neurexin 1beta signal peptide structural variants in patients with autism |
| 08/06/2009 | US20090197252 Detection of Mutations |
| 08/06/2009 | US20090197251 Process for marking products with nucleic acids for proving the identity and origin of the products |
| 08/06/2009 | US20090197250 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 08/06/2009 | US20090197249 Compositions and methods for diagnosing colon disorders |
| 08/06/2009 | US20090197248 Vitro evolution in microfluidic systems |
| 08/06/2009 | US20090197247 Composition for increasing microorganism wall permeability and method for detecting said microorganisms on a membrane |
| 08/06/2009 | US20090197246 Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies |
| 08/06/2009 | US20090197245 Rapid detection of dengue virus |
| 08/06/2009 | US20090197244 Method for typing and detecting HBV |
| 08/06/2009 | US20090197243 Method and composition for rapid viability testing of cells |
| 08/06/2009 | US20090197242 Lipidomic Approaches to Determining Drug Response Phenotypes in Cardiovascular Disease |
| 08/06/2009 | US20090196901 Tissue Engineering Methods and Compositions |
| 08/06/2009 | US20090196877 Novel Method to Increase Memory T Lymphocytes and Enhance Their Functions |
| 08/06/2009 | US20090196875 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening; neurodegenerative disease |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | US20090196864 Insecticides that target protein kinase a (pka) |
| 08/06/2009 | US20090196828 Contrast agent comprising a tm2+ containing luminescent substance for optical imaging |
| 08/06/2009 | US20090194429 Apparatus and Method for Sensing a Time Varying Ionic Current in an Electrolytic System |
| 08/06/2009 | US20090193897 Composition for material sensing and related method and apparatus |
| 08/06/2009 | DE102008007112B3 Verfahren zur Sequenzierung eines RNA-Moleküls mittels Massenspektrometrie A method of sequencing an RNA molecule by mass spectrometry |
| 08/06/2009 | DE102006014000B4 Verfahren zur Charakterisierung einer Mischprobe A method of characterizing a mixed sample |
| 08/06/2009 | CA2713839A1 Methods and kits for the rapid determination of patients at high risk of death during septic shock |
| 08/06/2009 | CA2713545A1 Two stage enrichment of cell-free fetal dna in maternal plasma |
| 08/06/2009 | CA2713469A1 Methods and compositions relating to carcinoma stem cells |
| 08/06/2009 | CA2706667A1 Method for studying v(d)j combinatory diversity |
| 08/06/2009 | CA2698463A1 Therapeutic kinase modulators |
| 08/05/2009 | EP2085780A2 Methods and products related to low molecular weight heparin |
| 08/05/2009 | EP2085487A1 Method for proving cytosine methylations in immobilised DNA samples |
| 08/05/2009 | EP2085486A1 Methods and kits for the rapid determination of patients at high risk of death during septic shock |
| 08/05/2009 | EP2085485A2 Method of diagnosis of cone-rod distrophy |
| 08/05/2009 | EP2085484A1 Method for identification of compound having antianxiety effect |
| 08/05/2009 | EP2085483A1 Test kit for detecting cancers |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085472A1 D-serine dehydratase and use thereof |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085096A2 Novel composition and methods for the treatment of immune related diseases |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2084540A2 Methods of treating, diagnosing or detecting cancer |
| 08/05/2009 | EP2084539A2 Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 08/05/2009 | EP2084519A2 Advanced drug development and manufacturing |
| 08/05/2009 | EP2084299A2 Method of prognosing recurrence of prostate cancer |
| 08/05/2009 | EP2084298A1 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |
| 08/05/2009 | EP2084297A2 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 08/05/2009 | EP2084296A2 High-throughput diagnostic testing using arrays |
| 08/05/2009 | EP2084295A2 Method for sequencing a polynucleotide template |
| 08/05/2009 | EP2084294A2 Sterilization indicator |
| 08/05/2009 | EP2084292A1 A reagent formulation using ruthenium hexamine as a mediator for electrochemical test strips |
| 08/05/2009 | EP2084282A2 Uncoupling of dna insert propagation and expression of protein for phage display |
| 08/05/2009 | EP2083850A2 Methods and compositions for stabilizing prostate specific antigen |
| 08/05/2009 | EP2083674A2 Transient decay amperometry |
| 08/05/2009 | EP2021512A4 Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets |
| 08/05/2009 | EP1963530A4 Active surface coupled polymerases |
| 08/05/2009 | EP1957676A4 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 08/05/2009 | EP1883707A4 Isothermal strand displacement amplification using primers containing a non-regular base |
| 08/05/2009 | EP1866432B1 Rapid-response gas sensing element |
| 08/05/2009 | EP1859051A4 Markers for prenatal diagnosis and monitoring |
| 08/05/2009 | EP1852700B1 Dry analysis element |
| 08/05/2009 | EP1842226A4 Homogeneous analyte detection |
| 08/05/2009 | EP1831399B1 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 08/05/2009 | EP1766065A4 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA |
| 08/05/2009 | EP1748845A4 Devices and methods for collection, storage and transportation of biological specimens |
| 08/05/2009 | EP1730301B1 Methods and compositions for analyzing ahasl genes |
| 08/05/2009 | EP1718739A4 Methods of refolding mammalian glycosyltransferases |
| 08/05/2009 | EP1685234A4 Method and device for replicating arrays of cell colonies |
| 08/05/2009 | EP1658504B1 Inhibition of s6 kinase activity for the treatment of insulin resistance |
| 08/05/2009 | EP1565565B1 Sol-gel biosensors |
| 08/05/2009 | EP1531803A4 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1404869B1 Detection of microorganisms using inducible genes |
| 08/05/2009 | EP1212468B1 Methods for disease detection |
| 08/05/2009 | EP1179086B1 Methods of identifying therapeutic compounds in a genetically defined setting |
| 08/05/2009 | EP1141335B1 Chemically modified enzymes with multiple charged variants |